Bergen New Bridge Medical Center has partnered with NeuroFlow, a behavioral health technology and analytics company, to help measure and manage population risk.
The Medical Center will integrate NeuroFlow’s workflow tools into their ambulatory care settings to improve identification of behavioral health needs and more effectively allocate care resources. The partnership will begin with an initial focus on providing care team members with the ability to track and measure patient progress in between appointments and improve resource allocation.
“We were looking for a way to identify and then prioritize behavioral health care needs in our patients, and this partnership with NeuroFlow will allow us to accomplish this by collecting essential data and helping to manage clinical decisions,” said Deborah Visconi, President & CEO, Bergen New Bridge Medical Center. “By addressing underlying, undiagnosed mental health conditions, we can better prevent crises. Operationally, we can enhance integration of all our healthcare resources, share data and information, and truly create customized care plans for everyone allowing us to treat the illness and care for the person.”
The Medical Center selected NeuroFlow because the platform will aggregate valuable population behavioral health data that will give providers the insights they need to deliver quality care and improve patient outcomes. The use of this technology has been proven to reduce visits to the emergency department, in research compiled with a large health system.
“We recognize that engaging vulnerable populations like those enrolled in Medicaid can be challenging, but it is imperative to address the complex and costly needs of this population,” said NeuroFlow Chief Medical Officer Tom Zaubler, MD. “That is why NeuroFlow leverages multiple access points – from SMS text to web, and in-clinic tablet flows – to lower the barriers to gathering critical data on patient behavioral health severity. We’re committed to delivering workflow tools designed to act as an extension of the clinical resources already in place, ultimately driving improved outcomes and financial sustainability within our clients’ organizations.”
NeuroFlow’s tech infrastructure will scale integrated care, enhancing both the reach and impact of these programs. These tools will empower Bergen New Bridge clinical teams to capture more patient screenings and data and enable proactive triage before symptoms escalate. NeuroFlow will also connect patients to other resources when appropriate, like community-based organizations that can help address social determinants of health (SDOH).
